[1]
Martins, R.G. , Advincula, G. , Costa, R. , Aragão, B. , Santos, W., Toscano, E. , Roriz, W. , Zamboni, M. , Sousa, A. , Biasi, P. de . y Zukin, M. 2004. Weekly Docetaxel as first-line chemotherapy in stage IV nonsmall cell lung cancer: effective treatment with low toxicity. Revista Brasileira de Cancerologia. 50, 4 (dic. 2004), 279–286. DOI:https://doi.org/10.32635/2176-9745.RBC.2004v50n4.2004.